Skip to main content
. 2022 Jan 27;8:790529. doi: 10.3389/fcvm.2021.790529

Table 4.

Summarize the features, advantages, application, challenges, and future directions of models discussed in the review.

Model Features Advantages Applications Challenges Directions
Single-cell Systems (2D) Seeding only one cell type in a tissue culture plate (TCP) - High availability
- Easy to make
- Cost-effective
- High reproducibility
- High throughput
- Evaluation of drug and drug delivery system
- Mechanistic studies
- Fail to mimic the native plaque composition and vascular structure - Creating a co-culture system
Direct Co-culture (2D) Direct cell-to-cell seeding of multicell types in a TCP - Study of cell-cell interaction and adhesion - Difficulty mimicking native physiological structures and proper development of cellular interactions with ECM - Using ECM
- mimicking scaffold
In-direct Transwell Co-culture (2D) Cells seeded in a TCP and trans-well inserts - Study of cellular responses via secretory pathways and cytokine production - Improving cell attachment
- Using ECM mimicking scaffold
Cell Sheet (2D) Layered structure seeded on the 2D scaffolds or no scaffolds - Better mimicking the vascular wall structure than other 2D systems
- Relatively easy to fabricate
- Potential for therapeutic evaluation
- Potential for studying cell-cell interaction
- Prone to spontaneous shrinkage or contraction
- Lacking adequate mechanical properties
- More expensive than TCP based systems
- Increasing mechanical property through other types of scaffolds
- Exploration of applications of such systems
Microfluidic Chip (2D) Endothelium seeded on a chip with a flow - Micro-analysis
- Providing continuous monitoring and medium supply
- Enhanced sensitivity
- Dynamic culture
- Relatively easy to make
- Mechanistic studies
- Nanomedicine evaluation
- Allowing real-time imaging
- Require additional types of equipment, such as pumps, tubing, and connectors
- Not adequately model 3D native environments
- Costly
- Using ECM mimicking scaffold
- Using multiple vascular cells observed in the plaque
Spheroid (3D) Cellular aggregates to provide 3D structures - Providing spherical structures
- Advanced plaque
- Mechanistic studies - Limited capability or function in comparison to native tissue
- Failing to provide the layered vascular structure
- Low quantity of spheroids
- Large production of this model
Cell-laden Hydrogel Construct (3D) Cells embedded within hydrogel scaffolds - Ability to provide an ECM mimicking environment provided by the scaffold
- relatively easy to make
- Mechanistic studies - Difficult to reproduce
- Poor mechanical properties
- Increase mechanical properties and reproducibility
- Controlling the properties of hydrogels
- Using these systems for various applications
Tissue-engineered Blood Vessel (3D) Models reproducing native vessel structure and size with or without disease features - Allowing controlled stimuli
- Providing partially vessel-like structure
- Dynamic culture
- Providing similar size to that of native vessels
- Drug evaluation
- Mechanistic studies
- Potential for medical device evaluation
- Allowing real-time imaging
- Majority are not developed using arterial cells
- Lacking the fibroblast layer
- Challenging to have a monolayer of endothelium
- Failing to induce advanced atherosclerotic plaques
- Expensive and difficult to reproduce
- Time-consuming
- Producing three-layered vessel
- Using arterial cells or stem cells
- Incorporating T and B cells in the system
- Large scale production for pharmaceutical use
- Improving reproducibility
- Providing advanced plaque
Vessel-on-a-chip (3D) Models reproducing vessel structures with or without disease feature on a micro-sized chip - Allowing controlled stimuli and real-time imaging
- Providing partially vessel-like structure
- Dynamic culture
- Applicable for drug screening
- Mechanistic studies
- Allowing real-time imaging
- Expensive and difficult to reproduce
- Additional equipment to create a dynamic microenvironment
- Lacking three-layered structures
- Time-consuming
- Inability to provide actual size vessel for medical device evaluation
- Limited to drug screening